Catalyst Wire Dossier Catalyst Wire Dossier

CARTIA XT

DILTIAZEM HYDROCHLORIDE · Actavis Pharma, Inc.
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for CARTIA XT, covering 2006-12-04 to 2026-01-24. Get the full timeline:

Most recent: FDA Approved: CARTIA XT — Supplemental Application (Actavis Pharma, Inc.)

See pricing